CKD Flashcards
1
Q
CKD is defined as?
A
- Presence of kidney damage or decrease in kidney function for 3 months or longer
- Seen by markers of damage or pathological abnormalities
- eGFR <60
- CKD is classified by: cause, GFR, albuminuria
2
Q
Glomerulonephritis (GN)
Specific diseses effect glomular filtration
A
- Lupes nephritis
- Post-infectous GN
- Congenital malformations
- Polycystic kidney disease
- Acute renal failure
3
Q
Risk factors for CKD chart
A
4
Q
Presentation
Stages
A
- 1/2 usually asymptomatic
- 3-4 minial symptoms
- Fatigue, edema, changes in urination (amount, color, frequency)
- 5
- Pruritus
- N/V/constipation
- Muscle pain
- Fatigue
- Bleeding abnormalities
5
Q
Systems affected by CKD
A
- Carbia/pulmonary
- Na retention: volume expansion edema
- Uremia: pericarditis, decreased contractility
- Anemia: high CO state, decreased oxygen delivery, left ventricle hypertophy
- GI
- Alt tastes, anorexia, N/V, hiccups
6
Q
CKD stages
A
7
Q
Cockcroft-Gault equations for calculating GFR?
A
8
Q
Markers of kindey damage?
A
- Albuminuria
- Urine sediment abnormalities
- Imaging abnormalities
- Assess these through: Urinalysis, SCr, Blood pressure, serum electrolytes and imaging studies.
9
Q
What will cause an increase or decrease in SCr?
A
Increase
- CKD
- AA
- Drugs that inhibit tubular secretion
- Ingestion of meat or creatine supplements
Decrease
- Reduced muscle mass (elderly, females)
- Malnutrition
- Amputation
- Vegan
10
Q
Albuminuria catagories and ACR values
A
- A1 <30
- A2 30-300
- A3 >300
11
Q
Nephrotoxic medications
A
- NSAIDs, Amphotericin B, Aminoglycosides, Cyclosporine, vancomycin, ACEs, ARBs
12
Q
Goals of CKD treatment
A
- Delay progression of CKD to ESRD
- Appropriate manage risk factors associated with CKD (Albuminuria, DM, HTN, HLD)
- Prevent and minimize complications associated with CKD (MBD and Anemia)
- Reduced mobidity and mortality associated with CKD
13
Q
Albuminuria indication?
Treatment?
Effectiveness?
A
- ACR >= 30 mg/g or AER >= 30 mg/24 hrs
- Treatment
- ACE
- ARBs
- CCBs if cant tolerate others
- Effectiveness
- With HTN: titrate dose until BP goal lower if tolerated
- Normotensive: titrate dose as tolerated and proteinuria reduced
14
Q
Albuminuria check what for when?
A
SCr, BUN, K+ 2-4 weeks after initiation of ACE/ARB
SCr increase
<30% no dose change
30-50 reduce dose and recheck in 1 week
>50% discontinue agent and recheck after 1 week
15
Q
Control related conditions
DM
HTN
A
DM
- A1c < 7%
- if >65 yo or significant comorbidities (stroke, MI, PVD, liver disease), consider goal A1c 7-8%
HTN
- <140/90 if ACR < 30
- <130/90 IF ACR > 30
- TREAT WITH ACE OR ARB